This is where our story unfolds. Follow our journey as we share our latest breakthroughs, strategic partnerships, and company milestones—all part of our mission to transform hearing loss from a lifelong condition to a treatable diagnosis. Stay connected with the developments that are reshaping what’s possible in hearing care.
May 26, 2026 – Strategic acquisition from Rescue Hearing Inc. expands and complements MED-EL comprehensive portfolio of inner ear solutions. Innsbruck, Austria — MED-EL Elektromedizinische Geräte GmbH, a global leader in hearing implant solutions, today announced the acquisition of two
May 19, 2022 – Rescue Hearing Inc. (RHI), a leader in innovative gene therapies for hearing loss, is thrilled to announce a strategic partnership with Myrtelle, a leading innovator in gene therapy solutions.
December 8th, 2021 – Rescue Hearing Inc. (RHI), a leader in innovative gene therapies for hearing loss, is proud to announce the appointment of Dr. Athanasia Warnecke, MD, PhD, to its Scientific Advisory Board. A renowned physician-scientist and senior researcher
June 1st, 2021 – Rescue Hearing Inc. (RHI) has reached an exciting milestone in the fight against genetic hearing loss. Our latest research has unveiled a novel gene therapy technique designed to restore hearing in individuals affected by STRC gene
February 11th, 2021 – Rescue Hearing Inc. (RHI), a team of visionary physicians, scientists, and bioengineers focused on developing new gene therapies to eliminate hearing loss, today announced significant research findings in the treatment of genetic hearing loss using AAV-mediated
October 13th, 2020 – Rescue Hearing Inc. (RHI), a team of visionary, internationally recognized physicians, scientists, and bioengineers focused on developing new gene therapies to eliminate hearing loss, announced the addition of Business Advisor Andrew Koopman.
PRESS RELEASE • MAY 2026
MED-EL has acquired full rights to Rescue Hearing’s MYO7A and STRC gene therapy programs, expanding research into gene-based therapeutic approaches targeting genetic causes of hearing and balance disorders.